ABSTRACT
Lactate has been shown to offer neuroprotection in several pathologic conditions. This beneficial effect has been attributed to its use as an alternative energy substrate. However, recent description of the expression of the HCA1 receptor for lactate in the central nervous system calls for reassessment of the mechanism by which lactate exerts its neuroprotective effects. Here, we show that HCA1 receptor expression is enhanced 24 hours after reperfusion in an middle cerebral artery occlusion stroke model, in the ischemic cortex. Interestingly, intravenous injection of L-lactate at reperfusion led to further enhancement of HCA1 receptor expression in the cortex and striatum. Using an in vitro oxygen-glucose deprivation model, we show that the HCA1 receptor agonist 3,5-dihydroxybenzoic acid reduces cell death. We also observed that D-lactate, a reputedly non-metabolizable substrate but partial HCA1 receptor agonist, also provided neuroprotection in both in vitro and in vivo ischemia models. Quite unexpectedly, we show D-lactate to be partly extracted and oxidized by the rodent brain. Finally, pyruvate offered neuroprotection in vitro whereas acetate was ineffective. Our data suggest that L- and D-lactate offer neuroprotection in ischemia most likely by acting as both an HCA1 receptor agonist for non-astrocytic (most likely neuronal) cells as well as an energy substrate.
Subject(s)
Brain Ischemia/drug therapy , Lactic Acid/therapeutic use , Neuroprotective Agents/therapeutic use , Animals , Behavior, Animal/drug effects , Brain Chemistry/drug effects , Brain Ischemia/pathology , Brain Ischemia/psychology , Carrier Proteins/biosynthesis , Carrier Proteins/genetics , Cell Death , Glucose/deficiency , Hippocampus/drug effects , Hypoxia, Brain/pathology , Immunohistochemistry , Kinetics , Male , Mice , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Organ Culture Techniques , Signal Transduction/physiology , StereoisomerismABSTRACT
Lactate, a product of glycolysis, has been shown to play a key role in the metabolic support of neurons/axons in the CNS by both astrocytes and oligodendrocytes through monocarboxylate transporters (MCTs). Despite such importance in the CNS, little is known about MCT expression and lactate function in the PNS. Here we show that mouse MCT1, MCT2, and MCT4 are expressed in the PNS. While DRG neurons express MCT1, myelinating Schwann cells (SCs) coexpress MCT1 and MCT4 in a domain-specific fashion, mainly in regions of noncompact myelin. Interestingly, SC-specific downregulation of MCT1 expression in rat neuron/SC cocultures led to increased myelination, while its downregulation in neurons resulted in a decreased amount of neurofilament. Finally, pure rat SCs grown in the presence of lactate exhibited an increase in the level of expression of the main myelin regulator gene Krox20/Egr2 and the myelin gene P0. These data indicate that lactate homeostasis participates in the regulation of the SC myelination program and reveal that similar to CNS, PNS axon-glial metabolic interactions are most likely mediated by MCTs.
Subject(s)
Gene Expression Regulation/physiology , Lactic Acid/metabolism , Monocarboxylic Acid Transporters/metabolism , Myelin Sheath/metabolism , Peripheral Nerves/metabolism , Sensory Receptor Cells/metabolism , Actins/metabolism , Age Factors , Animals , Animals, Newborn , Cell Adhesion Molecules, Neuronal/metabolism , Cells, Cultured , Coculture Techniques , Early Growth Response Protein 2/genetics , Embryo, Mammalian , Ganglia, Spinal/cytology , Gene Expression Regulation/drug effects , Humans , In Vitro Techniques , Lactic Acid/pharmacology , Male , Mice , Mice, Inbred C57BL , Monocarboxylic Acid Transporters/classification , Monocarboxylic Acid Transporters/genetics , Myelin Basic Protein/metabolism , Myelin P0 Protein/genetics , Neurofilament Proteins/metabolism , Peripheral Nerves/cytology , Rats , Rats, Sprague-Dawley , Schwann Cells/drug effects , Schwann Cells/metabolism , Sensory Receptor Cells/drug effectsABSTRACT
The monocarboxylate transporter MCT4 is a high capacity carrier important for lactate release from highly glycolytic cells. In the central nervous system, MCT4 is predominantly expressed by astrocytes. Surprisingly, MCT4 expression in cultured astrocytes is low, suggesting that a physiological characteristic, not met in culture conditions, is necessary. Here we demonstrate that reducing oxygen concentration from 21% to either 1 or 0% restored in a concentration-dependent manner the expression of MCT4 at the mRNA and protein levels in cultured astrocytes. This effect was specific for MCT4 since the expression of MCT1, the other astrocytic monocarboxylate transporter present in vitro, was not altered in such conditions. MCT4 expression was shown to be controlled by the transcription factor hypoxia-inducible factor-1α (HIF-1α) since under low oxygen levels, transfecting astrocyte cultures with a siRNA targeting HIF-1α largely prevented MCT4 induction. Moreover, the prolyl hydroxylase inhibitor dimethyloxalylglycine (DMOG) induced MCT4 expression in astrocytes cultured in presence of 21% oxygen. In parallel, glycolytic activity was enhanced by exposure to 1% oxygen as demonstrated by the increased lactate release, an effect dependent on MCT4 expression. Finally, MCT4 expression was found to be necessary for astrocyte survival when exposed for a prolonged period to 1% oxygen. These data suggest that a major determinant of astrocyte MCT4 expression in vivo is likely the oxygen tension. This could be relevant in areas of high neuronal activity and oxygen consumption, favouring astrocytic lactate supply to neurons. Moreover, it could also play an important role for neuronal recovery after an ischemic episode.
